CD8A and heart disorder: Production of the cytokine IFNγ by CD8+ T cells has been correlated with less severe cardiac disease [17]; therefore, a therapeutic vaccine which bolsters the TH1-mediated CD8+ T cell immune response to the infection, might slow or halt the progression of disease [18].